23andMe on Tuesday reported declining revenue in its most recent quarter, a day after the company said it will cut 40% of its workforce and shutter its therapeutics business as part of a business ...

“We are making significant progress to ensure the long-term success of the business as we continue on our mission,” said Anne Wojcicki, CEO and Co-Founder of 23andMe. “We have been focused on growing ...

Add Yahoo as a preferred source to see more of our stories on Google. One of the most popularly-recognized biotechnology companies, 23andMe, has filed for bankruptcy. Before the company sells it ...

SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, announced today that it will report financial ...

23andMe on Tuesday reported that second-quarter revenue fell to $44.1 million from $50 million a year earlier. The embattled genetics company said Monday that it's cutting about 200 jobs, or about 40% ...

One of the most popularly-recognized biotechnology companies, 23andMe, has filed for bankruptcy. Before the company sells it assets, users are able to download and delete their data, if they wish.